[ad_1]
“The violation of the 9 · 4 agreement … must be discussed in the agreement on drug limitation”
On the 6th, the president of the Korean Medical Association (Medical Association), the largest house, announced on the 6th that he would fight again if he did not stop immediately, stipulating that it is a ‘frontal violation of the 9 · 4 agreement’ for the Government sponsored oriental medicine acupuncture benefits pilot project.
President Choi told his social networking service (SNS) that day: “The Ministry of Health and Social Welfare formed a council limited to drugs in the demonstration project for consolidation benefits and is pushing it unilaterally without arguing that it is a frontal violation of the agreement of September 4. ” .
He noted that “the stability and efficacy of the herbal medicine used for the disease under the pilot project has not been verified, and the herbal medicine itself is a raw medicine that is very difficult to standardize and standardize, and it is very wrong to discuss the provision health insurance “.
“Therefore, the Medical College has always insisted on the principle that a consolidation benefits pilot project is only possible when the conditions for preliminary compliance are met.” Through this, a new limited drug advisory body was formed and an agreement was reached with the Ministry of Health and Welfare to review and discuss the pilot project in this committee. “
In addition, △ Immediately stop the demonstration project to gain consolidation benefits △ Limited drug council consultation and discussion was requested. I can’t help but make a decision, “he said, suggesting a willingness to resume the fight.
The government announced on the 4th that it will open a public offering for oriental medicine clinics and pharmacies to participate in the ‘Purpose Driven Health Insurance Application Pilot Project’ for approximately three years, from November this year to October 2023. Cheopyak is a herbal medicine and the diseases targeted by this pilot project are facial nerve palsy, the aftermath of cerebrovascular diseases, and menstrual pain. As it progresses, the price of drugs related to this is expected to be cut in half.
The medical association halted the group action on September 4 when it decided to re-discuss related policies by forming a legislative council with the government and the ruling party on September 4, after opposing government policy, including government policy.
On the other hand, the government is in the position that the benefits consolidation pilot project should continue, as it is a matter for the Health Insurance Policy Deliberation Committee.
President Choi said, “If patients with the relevant disease participate in this pilot project and take herbal medicines, the Medical Association will create a ‘patient management system to participate in the pilot medicine reimbursement project’ with the voluntary consent of patients “. He said: “We will actively consult and seek redress in civil and criminal lawsuits against victims of victims in case of damages by tracking deaths, misdiagnoses and delays in treatment time.
In addition, he added, “on the other hand, we will have strict liability not only for oriental medicine companies, but also for policy officials who conducted biological experiments on people by conducting pilot projects whose safety and effectiveness have not been verified. “.
Reason reporter [email protected]
Subscribe to the Hankook Ilbo News Naver channel
Balance to see the world, the Hankook Ilbo Copyright © Hankookilbo
[ad_2]